The global pharmaceutical excipients market was valued at USD 9.31 billion in 2025 and is projected to exceed USD 15.43 billion by 2034, growing at a CAGR of 5.75% from 2025 to 2034. This growth is driven by rising pharmaceutical production and increasing demand for innovative drug formulations.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Pharmaceutical Excipients Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Pharmaceutical Excipients Market, by Product
8.1.1. Organic Chemicals
8.1.1.1. Market Revenue and Forecast
8.1.2. Inorganic Chemicals
8.1.2.1. Market Revenue and Forecast
8.1.3. Others
8.1.3.1. Market Revenue and Forecast
9.1. Pharmaceutical Excipients Market, by Functionality
9.1.1. Fillers and Diluents
9.1.1.1. Market Revenue and Forecast
9.1.2. Suspending and Viscosity Agents
9.1.2.1. Market Revenue and Forecast
9.1.3. Coating Agents
9.1.3.1. Market Revenue and Forecast
9.1.4. Binders
9.1.4.1. Market Revenue and Forecast
9.1.5. Disintegrants
9.1.5.1. Market Revenue and Forecast
9.1.6. Colorants
9.1.6.1. Market Revenue and Forecast
9.1.7. Lubricants and Glidants
9.1.7.1. Market Revenue and Forecast
9.1.8. Preservatives
9.1.8.1. Market Revenue and Forecast
9.1.9. Emulsifying Agents
9.1.9.1. Market Revenue and Forecast
9.1.10. Flavoring Agents and Sweeteners
9.1.10.1. Market Revenue and Forecast
9.1.11. Other Functionalities
9.1.11.1. Market Revenue and Forecast
10.1. Pharmaceutical Excipients Market, by Formulations
10.1.1. Topical Formulations
10.1.1.1. Market Revenue and Forecast
10.1.2. Oral Formulations
10.1.2.1. Market Revenue and Forecast
10.1.3. Parenteral Formulations
10.1.3.1. Market Revenue and Forecast
10.1.3. Other Formulations
10.1.3.1. Market Revenue and Forecast
11.1. Pharmaceutical Excipients Market, by End-Users
11.1.1. Pharmaceuticals Companies
11.1.1.1. Market Revenue and Forecast
11.1.2. Research Organization
11.1.2.1. Market Revenue and Forecast
11.1.3. Academics
11.1.3.1. Market Revenue and Forecast
11.1.4. Other
11.1.4.1. Market Revenue and Forecast
12.1. Pharmaceutical Excipients Market, by Distribution Channel
12.1.1. Online Pharmacy
12.1.1.1. Market Revenue and Forecast
12.1.2. Retail
12.1.2.1. Market Revenue and Forecast
12.1.3. Mail-Order
12.1.3.1. Market Revenue and Forecast
12.1.4. Others
12.1.4.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product
13.1.2. Market Revenue and Forecast, by Functionality
13.1.3. Market Revenue and Forecast, by Formulations
13.1.4. Market Revenue and Forecast, by End-Users
13.1.5. Market Revenue and Forecast, by Distribution Channel
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product
13.1.6.2. Market Revenue and Forecast, by Functionality
13.1.6.3. Market Revenue and Forecast, by Formulations
13.1.6.4. Market Revenue and Forecast, by End-Users
13.1.7. Market Revenue and Forecast, by Distribution Channel
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Product
13.1.8.2. Market Revenue and Forecast, by Functionality
13.1.8.3. Market Revenue and Forecast, by Formulations
13.1.8.4. Market Revenue and Forecast, by End-Users
13.1.8.5. Market Revenue and Forecast, by Distribution Channel
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product
13.2.2. Market Revenue and Forecast, by Functionality
13.2.3. Market Revenue and Forecast, by Formulations
13.2.4. Market Revenue and Forecast, by End-Users
13.2.5. Market Revenue and Forecast, by Distribution Channel
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product
13.2.6.2. Market Revenue and Forecast, by Functionality
13.2.6.3. Market Revenue and Forecast, by Formulations
13.2.7. Market Revenue and Forecast, by End-Users
13.2.8. Market Revenue and Forecast, by Distribution Channel
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product
13.2.9.2. Market Revenue and Forecast, by Functionality
13.2.9.3. Market Revenue and Forecast, by Formulations
13.2.10. Market Revenue and Forecast, by End-Users
13.2.11. Market Revenue and Forecast, by Distribution Channel
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product
13.2.12.2. Market Revenue and Forecast, by Functionality
13.2.12.3. Market Revenue and Forecast, by Formulations
13.2.12.4. Market Revenue and Forecast, by End-Users
13.2.13. Market Revenue and Forecast, by Distribution Channel
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product
13.2.14.2. Market Revenue and Forecast, by Functionality
13.2.14.3. Market Revenue and Forecast, by Formulations
13.2.14.4. Market Revenue and Forecast, by End-Users
13.2.15. Market Revenue and Forecast, by Distribution Channel
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product
13.3.2. Market Revenue and Forecast, by Functionality
13.3.3. Market Revenue and Forecast, by Formulations
13.3.4. Market Revenue and Forecast, by End-Users
13.3.5. Market Revenue and Forecast, by Distribution Channel
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product
13.3.6.2. Market Revenue and Forecast, by Functionality
13.3.6.3. Market Revenue and Forecast, by Formulations
13.3.6.4. Market Revenue and Forecast, by End-Users
13.3.7. Market Revenue and Forecast, by Distribution Channel
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product
13.3.8.2. Market Revenue and Forecast, by Functionality
13.3.8.3. Market Revenue and Forecast, by Formulations
13.3.8.4. Market Revenue and Forecast, by End-Users
13.3.9. Market Revenue and Forecast, by Distribution Channel
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product
13.3.10.2. Market Revenue and Forecast, by Functionality
13.3.10.3. Market Revenue and Forecast, by Formulations
13.3.10.4. Market Revenue and Forecast, by End-Users
13.3.10.5. Market Revenue and Forecast, by Distribution Channel
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product
13.3.11.2. Market Revenue and Forecast, by Functionality
13.3.11.3. Market Revenue and Forecast, by Formulations
13.3.11.4. Market Revenue and Forecast, by End-Users
13.3.11.5. Market Revenue and Forecast, by Distribution Channel
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product
13.4.2. Market Revenue and Forecast, by Functionality
13.4.3. Market Revenue and Forecast, by Formulations
13.4.4. Market Revenue and Forecast, by End-Users
13.4.5. Market Revenue and Forecast, by Distribution Channel
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product
13.4.6.2. Market Revenue and Forecast, by Functionality
13.4.6.3. Market Revenue and Forecast, by Formulations
13.4.6.4. Market Revenue and Forecast, by End-Users
13.4.7. Market Revenue and Forecast, by Distribution Channel
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product
13.4.8.2. Market Revenue and Forecast, by Functionality
13.4.8.3. Market Revenue and Forecast, by Formulations
13.4.8.4. Market Revenue and Forecast, by End-Users
13.4.9. Market Revenue and Forecast, by Distribution Channel
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product
13.4.10.2. Market Revenue and Forecast, by Functionality
13.4.10.3. Market Revenue and Forecast, by Formulations
13.4.10.4. Market Revenue and Forecast, by End-Users
13.4.10.5. Market Revenue and Forecast, by Distribution Channel
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product
13.4.11.2. Market Revenue and Forecast, by Functionality
13.4.11.3. Market Revenue and Forecast, by Formulations
13.4.11.4. Market Revenue and Forecast, by End-Users
13.4.11.5. Market Revenue and Forecast, by Distribution Channel
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product
13.5.2. Market Revenue and Forecast, by Functionality
13.5.3. Market Revenue and Forecast, by Formulations
13.5.4. Market Revenue and Forecast, by End-Users
13.5.5. Market Revenue and Forecast, by Distribution Channel
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product
13.5.6.2. Market Revenue and Forecast, by Functionality
13.5.6.3. Market Revenue and Forecast, by Formulations
13.5.6.4. Market Revenue and Forecast, by End-Users
13.5.7. Market Revenue and Forecast, by Distribution Channel
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product
13.5.8.2. Market Revenue and Forecast, by Functionality
13.5.8.3. Market Revenue and Forecast, by Formulations
13.5.8.4. Market Revenue and Forecast, by End-Users
13.5.8.5. Market Revenue and Forecast, by Distribution Channel
14.1. Ashland Global Holdings
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. BASF SE
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. DuPont
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Roquette Feres
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Evonik Industries AG
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Associated British Foods
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Archer Daniels Midland Company
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Lubrizol Corporation
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Croda International
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Kerry Group
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description